John Jed Kennedy - Aug 30, 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Group Executive Vice President
Signature
Sarah M. Oliker for John (Jed) Kennedy by Power of Attorney
Stock symbol
CNMD
Transactions as of
Aug 30, 2021
Transactions value $
-$373,313
Form type
4
Date filed
8/31/2021, 05:13 PM
Previous filing
Aug 30, 2021
Next filing
Nov 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $153K +3.64K +49.36% $41.93 11K Aug 30, 2021 Direct
transaction CNMD Common Stock Sale -$490K -3.64K -33.05% $134.75 7.38K Aug 30, 2021 Direct F1
transaction CNMD Common Stock Options Exercise $18K +300 +4.07% $59.96 7.68K Aug 30, 2021 Direct
transaction CNMD Common Stock Sale -$40.4K -300 -3.91% $134.75 7.38K Aug 30, 2021 Direct
transaction CNMD Common Stock Options Exercise $7.88K +100 +1.36% $78.76 7.48K Aug 30, 2021 Direct
transaction CNMD Common Stock Sale -$13.5K -100 -1.34% $134.75 7.38K Aug 30, 2021 Direct
transaction CNMD Common Stock Options Exercise $19.5K +200 +2.71% $97.69 7.58K Aug 30, 2021 Direct
transaction CNMD Common Stock Sale -$27K -200 -2.64% $134.75 7.38K Aug 30, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -3.64K -38.31% $0.00 5.86K Aug 30, 2021 Common Stock 3.64K $41.93 Direct F2
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -300 -1.85% $0.00 15.9K Aug 30, 2021 Common Stock 300 $59.96 Direct F2
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -100 -1.32% $0.00 7.5K Aug 30, 2021 Common Stock 100 $78.76 Direct F3
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -200 -2.11% $0.00 9.3K Aug 30, 2021 Common Stock 200 $97.69 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $134.79. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F3 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period